Knoebl P, Marco P, Baudo F, et al. Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2). J Thromb Haemost 2012; 10(4): 622–31.
Delgado J, Jimenez-Yuste V, Hernandez-Navarro F, Villar A. Acquired haemophilia: review and meta-analysis focused on therapy and prognostic factors. Br J Haematol 2003; 121(1): 21–35.
Yee TT, Taher A, Pasi KJ, Lee CA. A survey of patients with acquired haemophilia in a haemophilia centre over a 28-year period. Clin Lab Haematol 2000; 22(5): 275–8.
O'Connor CR. Systematic review of the presentation of coagulation factor VIII inhibitors in rheumatic diseases: A potential cause of life-threatening hemorrhage. Semin Arthritis Rheum 2015; 44(6): 695–709.
Hay CR, Negrier C, Ludlam CA. The treatment of bleeding in acquired haemophilia with recombinant factor VIIa: a multicentre study. Thromb Haemost 1997; 78(6): 1463–7.
Lusher JM. Use of prothrombin complex concentrates in management of bleeding in hemophiliacs with inhibitors-benefits and limitations. Semin Hematol 1994; 31(2 Suppl 4): 49–52.
Giangrande P. Acquired hemophilia. Revised edition. Treatment of hemophilia, no. 38. World Federation of Hemophilia, 2012. Available from http://www1.wfh.org/publication/files/pdf-1186.pdf (accessed 25 November 2018).